In this model, hCD38 is only expressed on tumor cells; thus, the immune modulatory effects of hCD38-mAtt are likely indirect, as described above, which can facilitate the activation and anti-tumor function of NK cells and T cells. Here, TMEM79 is linked to neoplasm.